Analyze Diet

Development and duration of antibody response against Ehrlichia equi in horses.

Abstract: To characterize antibody response in horses with clinical signs of Ehrlichia equi infection. Methods: Prospective study. Methods: 13 horses with confirmed acute E equi infection. Methods: Sequential serum sampling was performed in Connecticut and New York during 1995 and 1996 to identify horses with naturally acquired equine granulocytic ehrlichiosis (EGE). Horses with clinical signs of EGE (i.e., fever without respiratory involvement) were confirmed as having E equi infection by polymerase chain reaction detection of ehrlichial DNA and by a minimum fourfold increase in total antibody titer by indirect fluorescent antibody staining methods. Infection was corroborated by use of DNA sequencing. Results: 11 of 13 horses did not have detectable antibody in serum samples obtained at onset of disease. Seroconversion was evident in samples obtained 19 to 81 days thereafter. Median time to peak antibody response was 46 days after onset and median titer was 1:320. For 11 of 13 horses, antibody titers were < or = 1:40 by 215 days after onset. Conclusions: E equi was found in horses in the northeastern United States and caused EGE. Concentration of antibodies to E equi increased within 19 to 81 days of disease onset and were low during early weeks of infection. Therefore, antibody detection may be of limited value for early serologic diagnosis. We suggest that disease may develop from a reinfection, and retrospective serologic studies to determine exposure to E equi may reflect a disproportionate number of negative reactions.
Publication Date: 1998-06-25 PubMed ID: 9638192
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research sought to determine and examine the development and duration of antibodies against an infection called Ehrlichia equi in horses. The study found that antibodies against the infection rise anywhere between 19 to 81 days after the onset of the disease, indicating that the testing for antibodies may not be a helpful method of early diagnosis.

Study Methods

  • The researchers carried out a prospective study involving 13 horses confirmed to have acute E equi infection.
  • In order to identify horses with naturally acquired equine granulocytic ehrlichiosis (EGE), a condition caused by E equi, sequential serum sampling was carried out in Connecticut and New York in 1995 and 1996.
  • The horses included in the study exhibited clinical signs of EGE, such as fever without respiratory involvement.
  • The infection was confirmed through polymerase chain reaction (PCR) detection of E equi DNA and by observing a minimum fourfold increase in total antibody count using indirect fluorescent antibody staining methods. DNA sequencing further corroborated the infection.

Study Results

  • At the beginning of the disease, 11 out of 13 horses did not have any detectable antibodies against the infection in their serum samples.
  • Seroconversion, the period during an infection when the antibodies begin to be detectable, was noticed in samples taken between 19 to 81 days after the disease began.
  • The researchers found that the median time to peak antibody response was 46 days after disease onset and a median titer of 1:320 was recorded.
  • For 11 of the 13 horses, antibody titers fell to less than or equal to 1:40, approximately 215 days after disease onset.

Study Conclusions

  • The infection, E equi, was found in horses in the northeastern United States and was determined to be causing EGE.
  • The concentration of antibodies against E equi was found to increase within 19 to 81 days of the onset of the disease but remained low during the early weeks of infection, suggesting that antibody detection may not be an effective method for early diagnosis.
  • The researchers suggested the possibility that disease may develop from reinfection, and retrospective serologic studies carried out to determine exposure to E equi may reflect a disproportionate number of negative reactions.

Cite This Article

APA
Van Andel AE, Magnarelli LA, Heimer R, Wilson ML. (1998). Development and duration of antibody response against Ehrlichia equi in horses. J Am Vet Med Assoc, 212(12), 1910-1914.

Publication

ISSN: 0003-1488
NlmUniqueID: 7503067
Country: United States
Language: English
Volume: 212
Issue: 12
Pages: 1910-1914

Researcher Affiliations

Van Andel, A E
  • Department of Epidemiology and Public Health, School of Medicine, Yale University, New Haven, CT 06520-8034, USA.
Magnarelli, L A
    Heimer, R
      Wilson, M L

        MeSH Terms

        • Acute Disease
        • Animals
        • Anti-Bacterial Agents / therapeutic use
        • Antibodies, Bacterial / biosynthesis
        • Antibodies, Bacterial / blood
        • Convalescence
        • DNA, Bacterial / blood
        • Ehrlichia / genetics
        • Ehrlichia / immunology
        • Ehrlichia / isolation & purification
        • Ehrlichiosis / drug therapy
        • Ehrlichiosis / immunology
        • Ehrlichiosis / veterinary
        • Fluorescent Antibody Technique, Indirect / veterinary
        • Horse Diseases / drug therapy
        • Horse Diseases / immunology
        • Horses
        • Prospective Studies
        • Tetracycline / therapeutic use

        Citations

        This article has been cited 5 times.
        1. Rule EK, Boyle AG, Stefanovski D, Anis E, Linton J, Lorello O. Transfer of naturally acquired specific passive immunity against Anaplasma phagocytophilum in foals in Southeastern Pennsylvania and Northern Maryland. J Vet Intern Med 2023 Sep-Oct;37(5):1889-1892.
          doi: 10.1111/jvim.16812pubmed: 37515307google scholar: lookup
        2. Giudice E, Giannetto C, Furco V, Alongi A, Torina A. Anaplasma phagocytophilum seroprevalence in equids: a survey in Sicily (Italy). Parasitol Res 2012 Aug;111(2):951-5.
          doi: 10.1007/s00436-012-2854-5pubmed: 22362364google scholar: lookup
        3. Levin ML, Fish D. Immunity reduces reservoir host competence of Peromyscus leucopus for Ehrlichia phagocytophila. Infect Immun 2000 Mar;68(3):1514-8.
        4. Chang YF, McDonough SP, Chang CF, Shin KS, Yen W, Divers T. Human granulocytic ehrlichiosis agent infection in a pony vaccinated with a Borrelia burgdorferi recombinant OspA vaccine and challenged by exposure to naturally infected ticks. Clin Diagn Lab Immunol 2000 Jan;7(1):68-71.
          doi: 10.1128/CDLI.7.1.68-71.2000pubmed: 10618280google scholar: lookup
        5. Gehlen H, Inerle K, Bartel A, Stöckle SD, Ulrich S, Briese B, Straubinger RK. Seroprevalence of Borrelia burgdorferi sensu lato and Anaplasma phagocytophilum Infections in German Horses. Animals (Basel) 2023 Jun 14;13(12).
          doi: 10.3390/ani13121984pubmed: 37370494google scholar: lookup